162 related articles for article (PubMed ID: 28623448)
21. Salvage pharyngolaryngectomy with total esophagectomy following definitive chemoradiotherapy.
Niwa Y; Koike M; Fujimoto Y; Oya H; Iwata N; Nishio N; Hiramatsu M; Kanda M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Nomoto S; Fujiwara M; Kodera Y
Dis Esophagus; 2016 Aug; 29(6):598-602. PubMed ID: 26338205
[TBL] [Abstract][Full Text] [Related]
22. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
[TBL] [Abstract][Full Text] [Related]
23. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
Lefebvre JL; Chevalier D; Luboinski B; Kirkpatrick A; Collette L; Sahmoud T
J Natl Cancer Inst; 1996 Jul; 88(13):890-9. PubMed ID: 8656441
[TBL] [Abstract][Full Text] [Related]
24. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
[TBL] [Abstract][Full Text] [Related]
25. Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer.
Okamoto H; Taniyama Y; Sakurai T; Heishi T; Teshima J; Sato C; Maruyama S; Ito K; Onodera Y; Konno-Kumagai T; Ishida H; Kamei T
Esophagus; 2018 Oct; 15(4):281-285. PubMed ID: 29948480
[TBL] [Abstract][Full Text] [Related]
26. Multimodal approach for cervical esophageal carcinoma: role of neoadjuvant chemotherapy.
Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Nakashima T; Tanaka T; Nakamura S; Yoshida K
Anticancer Res; 2014 Apr; 34(4):1989-92. PubMed ID: 24692736
[TBL] [Abstract][Full Text] [Related]
27. A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
Yokota T; Kato K; Hamamoto Y; Tsubosa Y; Ogawa H; Ito Y; Hara H; Ura T; Kojima T; Chin K; Hironaka S; Kii T; Kojima Y; Akutsu Y; Matsushita H; Kawakami K; Mori K; Makiuchi T; Nagumo R; Kitagawa Y
Ann Surg Oncol; 2020 Feb; 27(2):460-467. PubMed ID: 31376034
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.
Lu JC; Kong C; Tao H
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):710-4. PubMed ID: 20172661
[TBL] [Abstract][Full Text] [Related]
29. Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: goal of cure with organ preservation.
Wilson KS; Lim JT
Radiother Oncol; 2000 Feb; 54(2):129-34. PubMed ID: 10699475
[TBL] [Abstract][Full Text] [Related]
30. Cervical esophageal cancer: a gap in cancer knowledge.
Hoeben A; Polak J; Van De Voorde L; Hoebers F; Grabsch HI; de Vos-Geelen J
Ann Oncol; 2016 Sep; 27(9):1664-74. PubMed ID: 27117535
[TBL] [Abstract][Full Text] [Related]
31. Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Ishihara R; Yamamoto S; Iishi H; Takeuchi Y; Sugimoto N; Higashino K; Uedo N; Tatsuta M; Yano M; Imai A; Nishiyama K
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):123-9. PubMed ID: 19386426
[TBL] [Abstract][Full Text] [Related]
32. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
[TBL] [Abstract][Full Text] [Related]
33. Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer.
Nakashima T; Yasumatsu R; Asai K; Uryu H; Kogo R; Nakagawa T
Int J Clin Oncol; 2017 Jun; 22(3):442-447. PubMed ID: 28062933
[TBL] [Abstract][Full Text] [Related]
34. Short- and Long-Term Outcomes of Larynx-Preserving Surgery for Cervical Esophageal Cancer: Analysis of 100 Consecutive Cases.
Makino T; Yamasaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):858-865. PubMed ID: 27527716
[TBL] [Abstract][Full Text] [Related]
35. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
36. Weekly Chemotherapy of 5-Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study.
Chen B; Li Q; Li Q; Qiu B; Xi M; Liu M; Hu Y; Zhu Y
Oncologist; 2020 Apr; 25(4):308-e625. PubMed ID: 31880371
[TBL] [Abstract][Full Text] [Related]
37. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy.
Laterza E; Mosciaro O; Urso US; Inaspettato G; Cordiano C
Hepatogastroenterology; 1994 Jun; 41(3):278-82. PubMed ID: 7959554
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of radical radiotherapy alone for functional preservation of larynx in laryngeal carcinoma: a retrospective analysis.
Bhattacharyya T; Ghoshal S; Dhanireddy B; Kumar R; Sharma SC
Indian J Cancer; 2014; 51(1):10-4. PubMed ID: 24947088
[TBL] [Abstract][Full Text] [Related]
39. Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.
Valencia Julve J; Alonso Orduña V; Escó Barón R; López-Mata M; Méndez Villamón A
Clin Transl Oncol; 2006 Jan; 8(1):22-30. PubMed ID: 16632436
[TBL] [Abstract][Full Text] [Related]
40. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
